stars 1 stars 2 stars 3

Since 1993, GlobePharma has engineered solutions to pharma's toughest formulation and processing challenges — starting with our original Model I Unit-Dose Powder Sampler and expanding into a line of more than 25 sampling variations spanning bulk and unit-dose powder, liquid, and semi-solid applications. Today, GlobePharma offers a complete equipment portfolio for solid-dosage development and manufacturing, including MaxiBlend® and SimpleBlend® blenders from formulation through pilot scale, our patented Sift-N-Blend® technology, the VersaPress® rotary tablet press, GP-HSG High Shear Granulators, mills, DYNASEG™ powder segregation testing, and a full line of sampling, swabbing, and cleaning validation tools. Backed by 8 issued patents and more than three decades of hands-on formulation expertise, GlobePharma partners with pharmaceutical, nutraceutical, food, and cosmetics manufacturers worldwide to move products confidently from lab to pilot scale. INNOVATIVE · PROVEN · TRUSTED.

GlobePharma, Inc. Questions

The GlobePharma, Inc. annual revenue was $12 million in 2026.

Sameer Trikha is the Director, Strategy and Business Development of GlobePharma, Inc..

8 people are employed at GlobePharma, Inc..

GlobePharma, Inc. is based in New Brunswick, New Jersey.

The NAICS codes for GlobePharma, Inc. are [333, 33].

The SIC codes for GlobePharma, Inc. are [355, 35].

Top GlobePharma, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users